Development and validation of a predictive model for the risk of serious infection in patients with rheumatoid arthritis initiating a biologic or targeted synthetic DMARD: a nationwide cohort study.
To develop and validate a model to predict serious infection risk in rheumatoid arthritis (RA) patients initiating biologic or targeted synthetic DMARDs (b/tsDMARDs), and to implement it as an interactive tool (RAISE). We conducted a nationwide cohort study (2010-2023) using the…